Patents by Inventor George F. Lundell

George F. Lundell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
    Patent number: 5204349
    Abstract: Compounds of the formula: ##STR1## where R.sup.1 is hydrogen or hydroxy and R.sup.2 is a substituted amino group, a substituted heterocyclic ring or a substituted alkyl. These compounds are oxytocin and vasopressin antagonists useful in the treatment of preterm labor, dysmenorrhea and for the stoppage of labor preparatory to cesarean delivery, timing of parturition, uterine hyperactivity, endometriosis, hypertension, congestive heart failure, hyponatremia and cognitive disorders. Also disclosed are pharmaceutical compositions containing these compounds, methods of their use and methods of their preparation.
    Type: Grant
    Filed: September 16, 1991
    Date of Patent: April 20, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Mark G. Bock, Ben E. Evans, Roger M. Freidinger, Kevin Gilbert, Doug W. Hobbs, James B. Hoffman, George F. Lundell, Douglas J. Pettibone
  • Amino substituted tetrahydrobenzindoles
    Patent number: 4501900
    Abstract: Aminosubstituted tetrahydrobenzindoles having antihypertensive activity are disclosed.
    Type: Grant
    Filed: March 4, 1981
    Date of Patent: February 26, 1985
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, James H. Jones, George F. Lundell
  • Amino substituted tetrahydrobenzindoles
    Patent number: 4282240
    Abstract: Aminosubstituted tetrahydrobenzindoles having antihypertensive activity are disclosed.
    Type: Grant
    Filed: November 23, 1979
    Date of Patent: August 4, 1981
    Assignee: Merck & Co., Inc.
    Inventors: John J. Baldwin, James H. Jones, George F. Lundell